NCT07758842

Brief Summary

Metabolic syndrome is associated with erectile dysfunction through obesity, insulin resistance, abnormal blood lipids, high blood pressure, and impaired blood-vessel function. This study will evaluate whether a structured six-month lifestyle-modification program can improve penile blood flow and erectile function in men with metabolic syndrome-associated erectile dysfunction. Eligible participants will receive dietary counseling, exercise guidance, weight-management advice, smoking-cessation counseling when applicable, sleep and sedentary-behavior advice, and repeated behavioral reinforcement. Erectile function, penile blood-flow measurements obtained by penile duplex Doppler ultrasonography, body measurements, and selected metabolic laboratory parameters will be assessed before the program and after six months.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for not_applicable

Timeline
15mo left

Started Aug 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 6, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 11, 2026

Completed
14 days until next milestone

Study Start

First participant enrolled

August 25, 2026

Expected
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 24, 2027

4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 24, 2027

Last Updated

August 11, 2026

Status Verified

August 1, 2026

Enrollment Period

11 months

First QC Date

August 6, 2026

Last Update Submit

August 6, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in penile peak systolic velocity from baseline to six months

    Change in peak systolic velocity measured in centimeters per second by penile duplex Doppler ultrasonography after intracavernosal vasoactive-agent administration, comparing the baseline value with the six-month post-intervention value.

    Baseline and six months after initiation of the lifestyle-modification program.

Secondary Outcomes (5)

  • Change in erectile-function score

    Baseline and six months

  • Change in end-diastolic velocity

    Baseline and six months.

  • Change in resistive index

    Baseline and six months.

  • Change in body weight

    Baseline and six months.

  • Change in waist circumference

    Baseline and six months.

Study Arms (1)

Structured Lifestyle Modification

EXPERIMENTAL

Participants will receive a structured six-month lifestyle-modification program consisting of dietary counseling, moderate-intensity physical-activity advice, weight-management counseling, smoking-cessation counseling when applicable, sleep-hygiene advice, reduction of sedentary behavior, and monthly behavioral reinforcement.

Behavioral: Structured Lifestyle Modification Program

Interventions

Participants will receive an initial standardized counseling session followed by written lifestyle instructions and repeated monthly reinforcement. The program will target improved diet quality, reduced caloric intake, increased moderate-intensity aerobic activity, weight reduction according to baseline body mass index and waist circumference, smoking cessation when applicable, improved sleep hygiene, and reduced sedentary behavior. Adherence will be assessed using participant self-report and follow-up review over six months.

Structured Lifestyle Modification

Eligibility Criteria

Age30 Years - 65 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men aged 30-65 years.
  • Erectile dysfunction present for at least six months.
  • International Index of Erectile Function-5 score of 21 or less.
  • Metabolic syndrome diagnosed according to the International Diabetes Federation criteria.
  • Sexually active participants in a stable sexual relationship.
  • Willingness and ability to participate in the six-month lifestyle-modification program.
  • Ability to provide written informed consent.

You may not qualify if:

  • Erectile dysfunction primarily attributable to neurogenic, psychogenic, hormonal, or postsurgical causes.
  • Severe hypogonadism requiring immediate testosterone-replacement therapy.
  • Use of phosphodiesterase type 5 inhibitors, intracavernosal injections, vacuum erection devices, or other erectile-dysfunction treatment that cannot be discontinued before baseline assessment.
  • Significant penile anatomical abnormality that may interfere with penile duplex Doppler assessment, including Peyronie disease.
  • Previous pelvic surgery or pelvic radiotherapy likely to affect erectile function.
  • Severe or unstable cardiovascular disease that precludes sexual activity or participation in exercise-based lifestyle modification.
  • Uncontrolled diabetes mellitus, defined in the protocol as HbA1c greater than 10%.
  • Uncontrolled hypertension despite medical therapy.
  • Severe renal or hepatic impairment.
  • Active malignancy or life expectancy of less than one year.
  • Major psychiatric illness, cognitive impairment, or inability to comply with study procedures or follow-up.
  • Inability or refusal to provide written informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Erectile DysfunctionMetabolic Syndrome

Condition Hierarchy (Ancestors)

Genital Diseases, MaleGenital DiseasesUrogenital DiseasesSexual Dysfunction, PhysiologicalMale Urogenital DiseasesSexual Dysfunctions, PsychologicalMental DisordersInsulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Abul-fotouh Ahmed, MD

    Al-Azhar University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Participants will undergo a structured six-month lifestyle-modification program consisting of dietary counseling, advice regarding moderate-intensity aerobic physical activity, weight-management counseling, smoking-cessation counseling when applicable, sleep-hygiene advice, reduction of sedentary behavior, and behavioral reinforcement during follow-up visits.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Urology

Study Record Dates

First Submitted

August 6, 2026

First Posted

August 11, 2026

Study Start (Estimated)

August 25, 2026

Primary Completion (Estimated)

July 24, 2027

Study Completion (Estimated)

November 24, 2027

Last Updated

August 11, 2026

Record last verified: 2026-08